- Tytuł:
- Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases September 2019 19(9):1013-1022
Czasopismo naukowe